Eczematous external otitis is a chronic inflammatory disease and often difficult to treat. Our objective was to investigate the clinical effect and in vitro antibacterial potential of medical honey eardrops as treatment of eczematous external otitis. In a prospective study, 15 patients diagnosed with recurrent eczematous external otitis were treated with medical honey eardrops for 2 weeks. The following clinical outcomes were evaluated: visual analog scale of ear complaints, score of eczema, and eradication of bacterial infection. Furthermore, the antibacterial effect of honey eardrops against different bacterial strains was tested in vitro. Treatment resulted in less discomfort and itching and decreased signs of eczema, with high patient satisfaction and without adverse reactions. Honey eardrops showed a strong in vitro inhibitory activity against all tested strains but did not eradicate Staphylococcus aureus infection in vivo. The results of this preliminary study indicate a possible role of honey eardrops in eczematous ear disease.
czematous external otitis is a chronic inflammatory condition, mainly characterized by pruritus, erythema, and scaling. Exacerbations can be accompanied by acute secondary bacterial infections. 1 Topical corticosteroids are the first choice for the treatment of this condition 2 and are mainly used during acute flares. 3 A combination with antibiotics is effective for acute suppurative otitis. 4 Nevertheless, the prolonged use of steroids and antibiotics has major disadvantages, such as skin atrophy, 5 sensitization, and contact dermatitis. 6, 7 The recurrent use of antibiotic eardrops can lead to bacterial resistance. 8 Honey is more often used as an alternative treatment option for different diseases in otorhinolaryngology. 9 Honey has a strong antibacterial 10 and, to a lesser extent, antifungal property 11 and was found to be effective in some forms of dermatitis. 12, 13 The effect of medical honey eardrops for external auditory canal disease and their bactericidal capacity have not been studied previously.
The aim of this study was to investigate the applicability and effect of medical honey eardrops as a topical treatment of eczematous external otitis and to study their bactericidal capacity in vitro.
Methods

Patient Selection
This study was performed at the Maastricht University Medical Center1 and approved by the ethical committee (protocol 15-4-248). Patients with eczematous external otitis who were not treated 2 weeks prior to inclusion were recruited in a consecutive manner.
Intervention and Outcome Measures
After inclusion, patients completed a visual analog scale (VAS; scale, 0-10) about discomfort, otorrhea, pain, and itching of the affected ear. Standardized photos were taken of the external auditory canal with a rigid 0°otoscope, and a bacterial swab of the ear canal was taken. Patients were instructed to use honey eardrops (Otomel; Bfactory Health Products BV, Rhenen, the Netherlands) 3 times daily for 2 weeks. Patients returned after 1 week and again after 2 weeks. During both visits, a new VAS was completed; photos were taken; and during visit 3, a second bacterial swab was gathered. In addition, patients were asked to report treatment satisfaction. All standardized photos were scored by 2 blinded otologists on redness (score 0-3: 0 = none, 3 = severe) and scaling (score, 0-3: 0 = none, 3 = severe) and scaling outside the ear canal (0 = none, 1 = introitus, 2 = concha).
Broth Microdilution Assay
The bactericidal activity of honey eardrops and acid eardrops with hydrocortisone 1% was compared and assessed against clinical and nonclinical isolates (in a 2-fold microbroth dilution assay). Strains were incubated overnight, and the minimal inhibitory dilution was determined as the first dilution at which no growth was visible.
Statistical Analysis
Data was compared with the paired t test. Significance was determined to be at the confidence level of P \ .05.
Results
Patient Characteristics and Clinical Outcome
Fifteen patients were included in this study and treated with honey eardrops. Baseline characteristics are shown in Table  1 . Patients reported a baseline VAS score for discomfort of 5.3 6 3.3 (mean 6 SD), which was mainly based on itching (5.5 6 3.8) and, to a lesser extent, otorrhea (1.8 6 3.0) and pain (2.5 6 3.2). After treatment, VAS scores for discomfort and itching decreased significantly to 3.6 (P \ .01; 95% CI, 0.51-3.03) and 1.8 (P \ .01; 95% CI, 1.58-5.89), respectively ( Figure 1) . Furthermore, photos of the meatus, introitus, and concha were scored for redness and scaling before and after the treatment. The combined score decreased from 4.4 6 1.7 before treatment to 3.1 6 2.1 after it, which was statistically significant (P = .02; 95% CI, 0.15-2.28). Of all patients, a bacterial swab was taken before the treatment and at the end of the study. Four patients had an infection with Staphylococcus aureus and 1 with Candida parapsilosis. The rest showed colonization with commensal bacteria. After treatment, the culture changed from commensal colonization to a negative culture in 4 patients (27%). S aureus infections were not eradicated.
Patient Satisfaction and Adverse Reaction
Patients rated the treatment on a nonvalidated 7-point scale (0 = very dissatisfied, 6 = extremely satisfied). Ten patients were very satisfied (score, 5); 4 patients, satisfied to moderately satisfied; and 1 patient, not satisfied (score, 2). No adverse reactions with any correlation to medication use or study participation were reported.
Antibacterial Activity of Honey Eardrops
We tested the inhibitory activity of honey eardrops on different resistant and nonresistant pathogens, in comparison with acid eardrops with hydrocortisone 1%. Honey eardrops showed high inhibitory activity, inhibiting bacteria at concentrations ranging from 3% to 12.5%, which was comparable to acid eardrops ( Table 2 ) and independent of bacterial resistance.
Discussion and Conclusion
The pathophysiology of eczema involves a malfunction of the skin barrier.
14 Disadvantages of common topical preparations include skin atrophy, 5 sensitization, 6, 7 and bacterial resistance. 8 Honey mixture was an effective treatment in different types of dermatitis 12, 13, 15 and in animal external otitis and pruritus, without undesirable side effects. 16 In our study, honey eardrops reduced discomfort and mainly pruritus. We found high in vitro inhibitory activity of honey droplets, with strong efficiency against all strains. However, honey treatment could not eradicate S aureus infections in vivo and led only to less commensal colonization. The poor eradication of S aureus is in line with other studies, 17 possibly by growth within hair follicles 18 and redistribution from deeper skin layers. 19 This study was designed as a proof-of-concept study, with limitations including a small study size and the lack of a control group.
We showed that honey eardrops have a possible role in the treatment of eczematous ear disease, by reducing complaints and clinical signs of eczema and by a strong in vitro inhibitory activity against bacteria. This clears the way for further randomized studies. 
